
New!
Stock Analysis PRO
|
|
Stock Analysis |
|
Risk Assessment |
|
Trading Strategy |
|
Akebia Therapeutics stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session
(Updated on Jun 20, 2025)
The Akebia Therapeutics stock price gained 3.37% on the last trading day (Friday, 20th Jun 2025), rising from $3.56 to $3.68. During the last trading day the stock fluctuated 4.69% from a day low at $3.52 to a day high of $3.69. The price has risen in 6 of the last 10 days but is still down by -0.27% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 million more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately $34.28 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 99.66% during the next 3 months and, with a 90% probability hold a price between $6.40 and $8.55 at the end of this 3-month period.

AKBA Signals & Forecast
The Akebia Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.59 and $3.04. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 06, 2025, and so far it has fallen -7.30%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Akebia Therapeutics stock
Akebia Therapeutics finds support from accumulated volume at $3.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.165 between high and low, or 4.69%. For the last week, the stock has had daily average volatility of 4.37%.
Our recommended stop-loss: $3.49 (-5.29%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)
Trading Expectations (AKBA) For The Upcoming Trading Day Of Monday 23rd
For the upcoming trading day on Monday, 23rd we expect Akebia Therapeutics to open at $3.63, and during the day (based on 14 day Average True Range), to move between $3.47 and $3.89, which gives a possible trading interval of +/-$0.206 (+/-5.59%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 11.18% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.64 (1.09%) than the resistance at $3.83 (4.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Akebia Therapeutics stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Akebia Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score:
3.646
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 23, 2025 - $3.63 ( 1.40%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
AKBA Performance
Trading levels for AKBA
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 3.79 | 3.08% |
R2 | 3.73 | 1.37% |
R1 | 3.69 | 0.309% |
Price | 3.68 | |
S1 | 3.57 | -3.12% |
S2 | 3.53 | -4.17% |
S3 | 3.46 | -5.89% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 3.97 | 7.88% |
R2 | 3.92 | 6.52% |
R1 | 3.83 | 4.08% |
Price | 3.68 | |
S1 | 3.64 | -1.09% |
S2 | 3.56 | -3.26% |
S3 | 2.92 | -20.65% |
FAQ
Click here for our free guide on how to buy Akebia Therapeutics Stock.